In focus · trending topic

Phase 2b clinical trials

1 stories · following the connections

Ocera Therapeutics to Host KOL Conference Call on Hepatic Encephalopathy and Other Complications of Liver Disease on Friday, June 2

By Nasdaq OMXMay 26, 2017, 1:05 PM UTC